Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer

Circulating tumor-derived DNA is shorter than somatic DNA in plasma

(2015) Florent Mouliere et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer

(2014) Yuji Toiyama et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

(2014) Aaron M Newman et al.   NATURE MEDICINE

Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects

(2014) Daniel Neureiter   WORLD JOURNAL OF GASTROENTEROLOGY

Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature

(2013) Ola Ghatnekar et al.   INTERNATIONAL JOURNAL OF CANCER

Differential Regulation and Predictive Potential of MacroH2A1 Isoforms in Colon Cancer

(2012) Judith C. Sporn et al.   AMERICAN JOURNAL OF PATHOLOGY

Concise Review: Chromatin and Genome Organization in Reprogramming

(2012) Alva Biran et al.   STEM CELLS

Histone onco-modifications

(2011) J Füllgrabe et al.   ONCOGENE

Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development

(2010) T. Bianco-Miotto et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

(2010) Ananya Manuyakorn et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report

(2009) M. J. Duffy et al.   ANNALS OF ONCOLOGY

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

(2008) Yongkun Wei et al.   MOLECULAR CARCINOGENESIS